NEW YORK (GenomeWeb) – Illumina has selected three companies for the inaugural Illumina Accelerator funding cycle, the company said today.

Encoded Genomics, EpiBiome, and Xcell Biosciences will receive seed funding, as well as business advice as result of their selection. Additionally, they will have access to Illumina's sequencing systems and reagents and be provided fully operational laboratory space in the San Francisco Bay area during the six-month cycle.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.